The indication depends on the obstetric situation
NICE’s preterm-birth guidance recommends or considers intravenous magnesium sulfate within specified gestational-age ranges when birth is expected soon. The stated purpose is neuroprotection of the baby, not general supplementation. [1]
The recommendation is therefore tied to gestational age, likelihood of birth and individual circumstances. It is not an instruction for every pregnancy or every episode of contractions. [1]
Benefit and toxicity are managed together
The guidance calls for clinical monitoring, including breathing, blood pressure and tendon reflexes, and additional caution when kidney function is impaired. It does not recommend extending this neuroprotection regimen beyond its defined short duration. [1]
Do not interpret the use as proof that oral magnesium stops labor or that longer exposure provides more protection. The treatment plan belongs to the obstetric team. [1]
The reason for treatment changes the interpretation
Imagine magnesium is given shortly before a planned very preterm birth. The purpose may be protection of the baby’s developing nervous system, not correction of the mother’s diet or an attempt to replace her routine prenatal supplement.
| Detail | Interpretation |
|---|---|
| Neuroprotection | A specific clinical objective |
| Imminent preterm birth | Relevant setting |
| Prenatal nutrition | A separate question |
Sources for this article
- Recommendations | Preterm labour and birth | Guidance | NICE
Source consulted: 2026-09-17. This is a reference resource, not a claim that we conducted the studies or tested a product.